T-cell therapies have huge potential but face technical limitations. Here, the authors report on a dextran-based nanoparticle platform that efficiently expands T cells, enhances CAR T-cell potency, persistence, and anti-tumour efficacy, using simpler and faster methods than current techniques.
- Tao Zheng
- Keerthana Ramanathan
- Sine Reker Hadrup
